Preview, DCIS

Ductal carcinoma in situ, or DCIS, makes up 25% of breast cancers and is lethal in only 1-2%. Failure to differentiate leads to massive over treatment, significant emotional and physical disability, and unnecessary treatment and costs. There is a desperate need for better screening tests. Many of these cancers spontaneously disappear.